Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Eingun James

Song

,

MD, FAAD

Director of Clinical Research, Co-Chief Medical Officer
Frontier Dermatology
Mill Creek
,
Washington
,
United States
Councilor Since: June 14, 2024
IPC Councilor
Dr. Eingun James Song completed his residency training at the University of California Irvine, where he became interested in inflammatory skin diseases. After graduating from residency, Dr. Song focused on complex medical dermatology, many of which were difficult to treat psoriasis patients. He eventually started the clinical trials center at his current practice, which gave his patients early access to various investigational therapies for psoriasis. Dr. Song also serves as the affiliate residency program director for Silver Falls Dermatology, participating regularly in resident education. More recently, Dr. Song has become the Co-Chief Medical Officer of Frontier Dermatology, which has allowed him to focus on optimizing office workflow for patients with inflammatory skin disorders on a much larger scale. Dr. Song serves on numerous editorial boards, including senior editor of the Journal of Psoriasis and Psoriatic Arthritis, Journal of Dermatology Nurse Practitioners & Physician Assistants, and associate editor of the Journal of the American Academy of Dermatology.
Last Updated:
06/26/2024

Areas of Interest

Clinical trial development for investigational psoriasis therapies; optimizing office workflow to ensure efficient yet comprehensive visits while minimizing treatment delay

IPC Committees / Groups

Generalized Pustular Psoriasis (GPP) Working Group

Languages Spoken

English

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026